Oncology & Cancer

SBRT, proton beam therapy use increasing for prostate CA

(HealthDay)—For men with prostate cancer, the use of stereotactic body radiotherapy (SBRT) and proton beam therapy increased from 2004 to 2011, according to a study published online May 25 in Cancer.

Oncology & Cancer

Study provides evidence for new approaches to prostate cancer

Monitoring prostate cancer (PC) by active surveillance (AS), with the expectation to initiate treatment if the cancer progresses, is a preferred initial option for men with low-risk PC and a life expectancy of at least 10 ...

Oncology & Cancer

Active surveillance cost-effective for prostate cancer

(HealthDay) -- In a theoretical cohort of 120,000 men, selecting active surveillance for prostate cancer results in considerable cost savings at five and 10 years of follow-up, compared with immediate treatment, according ...

page 1 from 2